Airway diseases
Respiratory critical care
E-poster
Pharmacology of airway diseases: clinical and laboratory studies
Aims : This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Methods :
Public health, Cell and molecular biology, Endoscopy and interventional pulmonology, Pulmonary rehabilitation
Chairs
A. Higham
Manchester (Greater Manchester)
(United Kingdom)
GRC39815-A novel inhaled ROR?t inhibitor as a potential first in class treatment option for COPD
A. Kulkarni(Navi Mumbai (Maharashtra), India)
COI
1
Beclomethasone, formoterol and glycopyrronium: synergy of dual and triple combinations in an ex vivo model of COPD exacerbation
L. Calzetta(Roma (RM), Italy)
COI
2
Adding glycopyrronium to beclomethasone/formoterol combination: synergistic effect on human medium bronchi of COPD donors
P. Rogliani(Roma (RM), Italy)
COI
3
Impact of Bronchial Rheoplasty on exacerbations in chronic bronchitis: a US feasibility study
V. Kim(Philadelphia, United States)
COI
4
Bronchial Rheoplasty improves respiratory and sleep symptoms in chronic bronchitis
V. Kim(Philadelphia, United States)
COI
5
Exploring the molecular potential of bacterial lysates to reduce COVID-19 susceptibility of bronchial epithelial cells in vitro
L. Fang(Basel, Switzerland)
COI
6
Imiquimod shows anti-viral actions in human bronchial epithelium - implications for COVID-19 treatment
S. Malm Tillgren(Lund, Sweden)
COI
7
The effect of fluconazole on the pharmacokinetics of ensifentrine in healthy individuals
T. Rheault(Raleigh, United States)
COI
8
1-?-alkyl-glycerols Reduce Level of Inflammatory Cytokines In Obese Asthma
Y. Denisenko(Vladivostok, Russian Federation)
COI
9
The Impact of Conjugated Pneumococcal Vaccine on Exacerbation Frequency in Patients with COPD
Y. Varol(Izmir, Turkey)
COI
10
. . .